Bajaj Healthcare Limited (BHL), an Indian manufacturer of APIs, intermediates, and formulations, has launched Magnesium L-Threonate as part of its nutraceutical segment.

The company has launched the neuroprotective agent in capsule form for oral administration in the strength of 500mg.

Magnesium L-Threonate is used for preventing the loss of synapses and to boost the cognitive functions of the brain.

Anil Jain — Joint Managing Director at Bajaj Healthcare said: “We are pleased to add Magnesium L-Threonate to our growing product portfolio and continue to carry through, Bajaj’s commitment to deliver therapeutical products every year.

“BHL intend to produce 12-15 tons of Magnesium L-Threonate in Q4 FY22 and 120 tons in FY23. We are expecting notable sales coming from the product. Addition of this new product in our existing product portfolio will further fuel the growth strategy for our formulation business.

“Addition of Magnesium LThreonate in our existing portfolio will further fuel the growth of our business and strengthen our position in the market.”

  Anil Jain, Bajaj Healthcare Limited, India, Magnesium L-Threonate